Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by PinnacleXon Oct 27, 2023 3:48pm
103 Views
Post# 35704850

RE:RE:RE:RE:RE:Hard to connect the dots since the September 26 th CC

RE:RE:RE:RE:RE:Hard to connect the dots since the September 26 th CC
PWIB123 wrote: 100%.  There's no integrity over there.  I saw it several times before.  I should have stuck to my principles and sold on that single leadership flaw alone.  I was greedy and hoping for oncology to be a blockbuster opportunity, so I looked past the leadership.  Lots of excuses made for these guys.  Those are clearly proving to have been unwarranted.  
ITs not greed, its human nature, we turn into a deer in the headlights we freeze and do nothing.  I still have some , but sold alot on the way down as I noticed the lies and deciet from this garbage run company.  

<< Previous
Bullboard Posts
Next >>